| Product Code: ETC10765601 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Fiji continued to import significant volumes of pemetrexed with key suppliers such as Australia, New Zealand, India, Bangladesh, and the USA. Despite a slight decrease in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) for the period 2020-2024 remained strong at 6.89%. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, suggesting potential challenges and opportunities for market participants in the pemetrexed import industry in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Pemetrexed Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Pemetrexed Market - Industry Life Cycle |
3.4 Fiji Pemetrexed Market - Porter's Five Forces |
3.5 Fiji Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Fiji Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Fiji Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Fiji Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Fiji Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Fiji Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Fiji Pemetrexed Market Trends |
6 Fiji Pemetrexed Market, By Types |
6.1 Fiji Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Fiji Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Fiji Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Fiji Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Fiji Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Fiji Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Fiji Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Fiji Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Fiji Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Fiji Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Fiji Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Fiji Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Fiji Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Fiji Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Fiji Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Fiji Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Fiji Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Fiji Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Fiji Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Fiji Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Fiji Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Fiji Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Fiji Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Fiji Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Fiji Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Fiji Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Fiji Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Fiji Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Fiji Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Fiji Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Fiji Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Fiji Pemetrexed Market Import-Export Trade Statistics |
7.1 Fiji Pemetrexed Market Export to Major Countries |
7.2 Fiji Pemetrexed Market Imports from Major Countries |
8 Fiji Pemetrexed Market Key Performance Indicators |
9 Fiji Pemetrexed Market - Opportunity Assessment |
9.1 Fiji Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Fiji Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Fiji Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Fiji Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Fiji Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Fiji Pemetrexed Market - Competitive Landscape |
10.1 Fiji Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Fiji Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here